Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5179 studies found for:    Lung Diseases, Obstructive
Show Display Options
Rank Status Study
1 Unknown  Outpatient Management of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Procedure: Patient education and disease management
2 Terminated Portable Monitoring Device for the Diagnosis of Sleep Apnea in Patients With Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Obstructive Sleep Apnea Syndrome
Intervention: Device: Polysomnography
3 Completed Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study
Condition: Pulmonary Disease, Chronic Obstructive
Intervention:
4 Completed A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
5 Unknown  Cognitive Status in Chronic Obstructive Pulmonary Disease's Patients
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Other: Cognitive assessment
6 Completed Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General Practice
Condition: Lung Diseases, Obstructive
Interventions: Behavioral: an integrated self-management education program;   Behavioral: regular practice nurse review (monitoring controls);   Behavioral: care at initiative of the patient (usual GP care)
7 Completed Transcutaneous Electrical Muscle Stimulation In Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Device: Transcutaneous electrical muscle stimulation
8 Completed A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Biological: MEDI8968 SC for 12 months;   Biological: Placebo SC for 12 months
9 Completed Metformin in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Metformin;   Drug: Placebo
10 Completed
Has Results
Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: NVA237 100 µg;   Drug: Placebo;   Drug: NVA237 200 µg
11 Not yet recruiting Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Radiation: AxV-128/Tc SPECT-CT imaging
12 Completed Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: GS-5745;   Drug: Placebo to match GS-5745
13 Completed
Has Results
Chronic Obstructive Pulmonary Disease Markers and Prognosis
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
14 Recruiting Non-invasive Positive Pressure (NPPV ) for Severe Stable Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Hypercapnic Respiratory Failure
Intervention: Device: BiPAP mode
15 Completed
Has Results
A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Biological: MEDI2338;   Other: Placebo
16 Completed
Has Results
Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: NVA237;   Drug: Placebo
17 Completed Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study.
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Behavioral: control;   Behavioral: pharmaceutical care intervention
18 Completed Is COPD a Risk Factor for Cardiovascular Disease?
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
19 Completed
Has Results
Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Indacaterol 150 μg;   Drug: Salmeterol 50 μg;   Drug: Placebo to Indacaterol;   Drug: Placebo to Salmeterol
20 Completed
Has Results
Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Budesonide/formoterol (Symbicort® Turbuhaler®);   Drug: Tiotropium (SpirivaTM)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.